 | • レポートコード：MRC2102QY6362 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：材料、化学 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のヘパリン市場について種類別（ヘパリンナトリウム、ヘパリンカルシウム、その他）、用途別（UFH、LMWH）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ヘパリン市場の概要 ・世界の主要地域別ヘパリン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヘパリン市場規模2015-2026：種類別（ヘパリンナトリウム、ヘパリンカルシウム、その他） ・世界のヘパリン市場規模2015-2026：用途別（UFH、LMWH） ・ヘパリンの米国市場規模2015-2020 ・ヘパリンのヨーロッパ市場規模2015-2020 ・ヘパリンの中国市場規模2015-2020 ・ヘパリンの日本市場規模2015-2020 ・ヘパリンの東南アジア市場規模2015-2020 ・ヘパリンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ヘパリンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヘパリンの市場動向・機会・課題 ・調査の結論 |
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine
Heparin API is an anticoagulant (blood thinner) that prevents the formation of blood clots. With the accelerated pace of life and increasing aging population, global morbidity and mortality of cardiovascular and cerebrovascular disease are increased year by year. Heparin API is an efficient solution to those diseases.
Raw materials of Heparin API are mainly porcine intestine, bovine lung and bovine intestine, etc. China pig slaughter amount accounted for more than 50% of the world. It has most abundant raw material resources all over the world.
The classification of Heparin includes Heparin Sodium, Heparin Calcium and others, and the proportion of Heparin Sodium in 2016 is about 88%, and the proportion is in decreasing trend from 2012 to 2016.
Heparin is widely used UFH and LMWH. The most proportion of Heparin is used in LMWH, and the proportion in 2016 is 88.9%
Europe is the largest consumption place, with a consumption market share nearly 40% in 2016. Following Europe, United Stated is the second largest consumption place with the consumption market share of 36%.
Market competition is not intense. Hepalink, Bioibérica, Changshan Pharm, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Heparin Market
The global Heparin market size is projected to reach US$ 1339 million by 2026, from US$ 1095.6 million in 2020, at a CAGR of 3.4% during 2021-2026.
Global Heparin Scope and Market Size
The global Heparin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Heparin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Heparin market is segmented into
Heparin Sodium
Heparin Calcium
Other
Segment by Application, the Heparin market is segmented into
UFH
LMWH
The Heparin market is analysed and market size information is provided by regions (countries). Segment by Application, the Heparin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Heparin Market Share Analysis
Heparin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Heparin business, the date to enter into the Heparin market, Heparin product introduction, recent developments, etc.
The major vendors covered:
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma
Deebio
1 Heparin Market Overview
1.1 Heparin Product Scope
1.2 Heparin Segment by Type
1.2.1 Global Heparin Sales by Type (2020-2026)
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.2.4 Other
1.3 Heparin Segment by Application
1.3.1 Global Heparin Sales Comparison by Application (2020-2026)
1.3.2 UFH
1.3.3 LMWH
1.4 Heparin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Heparin Sales Growth Rate (2015-2026)
1.4.2 Global Heparin Revenue and Growth Rate (2015-2026)
1.4.3 Global Heparin Price Trends (2015-2026)
2 Heparin Estimate and Forecast by Region
2.1 Global Heparin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Heparin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Heparin Sales Market Share by Region (2015-2020)
2.2.2 Global Heparin Revenue Market Share by Region (2015-2020)
2.3 Global Heparin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Heparin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Heparin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Heparin Estimates and Projections (2015-2026)
2.4.2 Europe Heparin Estimates and Projections (2015-2026)
2.4.3 China Heparin Estimates and Projections (2015-2026)
2.4.4 Japan Heparin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Heparin Estimates and Projections (2015-2026)
2.4.6 India Heparin Estimates and Projections (2015-2026)
3 Global Heparin Competition Landscape by Players
3.1 Global Top Heparin Players by Sales (2015-2020)
3.2 Global Top Heparin Players by Revenue (2015-2020)
3.3 Global Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heparin as of 2019)
3.4 Global Heparin Average Price by Company (2015-2020)
3.5 Manufacturers Heparin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Heparin Players (Opinion Leaders)
4 Global Heparin Market Size by Type
4.1 Global Heparin Historic Market Review by Type (2015-2020)
4.1.1 Global Heparin Sales Market Share by Type (2015-2020)
4.1.2 Global Heparin Revenue Market Share by Type (2015-2020)
4.1.3 Global Heparin Price by Type (2015-2020)
4.2 Global Heparin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Heparin Sales Forecast by Type (2021-2026)
4.2.2 Global Heparin Revenue Forecast by Type (2021-2026)
4.2.3 Global Heparin Price Forecast by Type (2021-2026)
5 Global Heparin Market Size by Application
5.1 Global Heparin Historic Market Review by Application (2015-2020)
5.1.1 Global Heparin Sales Market Share by Application (2015-2020)
5.1.2 Global Heparin Revenue Market Share by Application (2015-2020)
5.1.3 Global Heparin Price by Application (2015-2020)
5.2 Global Heparin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Heparin Sales Forecast by Application (2021-2026)
5.2.2 Global Heparin Revenue Forecast by Application (2021-2026)
5.2.3 Global Heparin Price Forecast by Application (2021-2026)
6 United States Heparin Market Facts & Figures
6.1 United States Heparin Sales Market Share by Company (2015-2020)
6.2 United States Heparin Sales Market Share by Type (2015-2020)
6.3 United States Heparin Sales Market Share by Application (2015-2020)
7 Europe Heparin Market Facts & Figures
7.1 Europe Heparin Sales Market Share by Company (2015-2020)
7.2 Europe Heparin Sales Market Share by Type (2015-2020)
7.3 Europe Heparin Sales Market Share by Application (2015-2020)
8 China Heparin Market Facts & Figures
8.1 China Heparin Sales Market Share by Company (2015-2020)
8.2 China Heparin Sales Market Share by Type (2015-2020)
8.3 China Heparin Sales Market Share by Application (2015-2020)
9 Japan Heparin Market Facts & Figures
9.1 Japan Heparin Sales Market Share by Company (3015-3030)
9.2 Japan Heparin Sales Market Share by Type (2015-2020)
9.3 Japan Heparin Sales Market Share by Application (2015-2020)
10 Southeast Asia Heparin Market Facts & Figures
10.1 Southeast Asia Heparin Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Heparin Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Heparin Sales Market Share by Application (2015-2020)
11 India Heparin Market Facts & Figures
11.1 India Heparin Sales Market Share by Company (2015-2020)
11.2 India Heparin Sales Market Share by Type (2015-2020)
11.3 India Heparin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Heparin Business
12.1 Hepalink
12.1.1 Hepalink Corporation Information
12.1.2 Hepalink Business Overview
12.1.3 Hepalink Heparin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Hepalink Heparin Products Offered
12.1.5 Hepalink Recent Development
12.2 Changshan Pharm
12.2.1 Changshan Pharm Corporation Information
12.2.2 Changshan Pharm Business Overview
12.2.3 Changshan Pharm Heparin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Changshan Pharm Heparin Products Offered
12.2.5 Changshan Pharm Recent Development
12.3 Qianhong Bio-pharma
12.3.1 Qianhong Bio-pharma Corporation Information
12.3.2 Qianhong Bio-pharma Business Overview
12.3.3 Qianhong Bio-pharma Heparin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Qianhong Bio-pharma Heparin Products Offered
12.3.5 Qianhong Bio-pharma Recent Development
12.4 Opocrin
12.4.1 Opocrin Corporation Information
12.4.2 Opocrin Business Overview
12.4.3 Opocrin Heparin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Opocrin Heparin Products Offered
12.4.5 Opocrin Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Heparin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Heparin Products Offered
12.5.5 Pfizer Recent Development
12.6 Aspen Oss
12.6.1 Aspen Oss Corporation Information
12.6.2 Aspen Oss Business Overview
12.6.3 Aspen Oss Heparin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Aspen Oss Heparin Products Offered
12.6.5 Aspen Oss Recent Development
12.7 King-friend Biochemical Pharmaceutical
12.7.1 King-friend Biochemical Pharmaceutical Corporation Information
12.7.2 King-friend Biochemical Pharmaceutical Business Overview
12.7.3 King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 King-friend Biochemical Pharmaceutical Heparin Products Offered
12.7.5 King-friend Biochemical Pharmaceutical Recent Development
12.8 Bioibérica
12.8.1 Bioibérica Corporation Information
12.8.2 Bioibérica Business Overview
12.8.3 Bioibérica Heparin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bioibérica Heparin Products Offered
12.8.5 Bioibérica Recent Development
12.9 Dongcheng Biochemicals
12.9.1 Dongcheng Biochemicals Corporation Information
12.9.2 Dongcheng Biochemicals Business Overview
12.9.3 Dongcheng Biochemicals Heparin Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Dongcheng Biochemicals Heparin Products Offered
12.9.5 Dongcheng Biochemicals Recent Development
12.10 Jiulong Biochemicals
12.10.1 Jiulong Biochemicals Corporation Information
12.10.2 Jiulong Biochemicals Business Overview
12.10.3 Jiulong Biochemicals Heparin Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Jiulong Biochemicals Heparin Products Offered
12.10.5 Jiulong Biochemicals Recent Development
12.11 Tiandong
12.11.1 Tiandong Corporation Information
12.11.2 Tiandong Business Overview
12.11.3 Tiandong Heparin Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Tiandong Heparin Products Offered
12.11.5 Tiandong Recent Development
12.12 Xinbai
12.12.1 Xinbai Corporation Information
12.12.2 Xinbai Business Overview
12.12.3 Xinbai Heparin Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Xinbai Heparin Products Offered
12.12.5 Xinbai Recent Development
12.13 Yino Pharma
12.13.1 Yino Pharma Corporation Information
12.13.2 Yino Pharma Business Overview
12.13.3 Yino Pharma Heparin Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Yino Pharma Heparin Products Offered
12.13.5 Yino Pharma Recent Development
12.14 Deebio
12.14.1 Deebio Corporation Information
12.14.2 Deebio Business Overview
12.14.3 Deebio Heparin Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Deebio Heparin Products Offered
12.14.5 Deebio Recent Development
13 Heparin Manufacturing Cost Analysis
13.1 Heparin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Heparin
13.4 Heparin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Heparin Distributors List
14.3 Heparin Customers
15 Market Dynamics
15.1 Heparin Market Trends
15.2 Heparin Opportunities and Drivers
15.3 Heparin Market Challenges
15.4 Heparin Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Heparin Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Heparin Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Heparin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Heparin Sales (K MT) by Region (2015-2020)
Table 5. Global Heparin Sales Market Share by Region (2015-2020)
Table 6. Global Heparin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Heparin Revenue Share by Region (2015-2020)
Table 8. Global Heparin Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Heparin Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Heparin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Heparin Revenue Share Forecast by Region (2021-2026)
Table 12. Global Heparin (K MT) of Key Companies (2015-2020)
Table 13. Global Heparin Sales Share by Company (2015-2020)
Table 14. Global Heparin Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Heparin Revenue Share by Company (2015-2020)
Table 16. Global Heparin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heparin as of 2019)
Table 17. Global Heparin Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Heparin Manufacturing Sites and Area Served
Table 19. Manufacturers Heparin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Heparin Players
Table 22. Global Heparin Sales (K MT) by Type (2015-2020)
Table 23. Global Heparin Sales Share by Type (2015-2020)
Table 24. Global Heparin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Heparin Price (K MT) by Type (2015-2020)
Table 26. Global Heparin Sales Share by Type (2021-2026)
Table 27. Global Heparin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Heparin Revenue Share by Type (2021-2026)
Table 29. Global Heparin Price (K MT) by Type (2021-2026)
Table 30. Global Heparin Sales (K MT) by Application (2015-2020)
Table 31. Global Heparin Sales Share by Application (2015-2020)
Table 32. Global Heparin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Heparin Price (K MT) by Application (2015-2020)
Table 34. Global Heparin Sales (K MT) by Application (2021-2026)
Table 35. Global Heparin Sales Share by Application (2021-2026)
Table 36. Global Heparin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Heparin Revenue Share by Application (2021-2026)
Table 38. Global Heparin Price (K MT) by Application (2021-2026)
Table 39. United States Heparin Sales (K MT) by Company (2015-2020)
Table 40. United States Heparin Sales Market Share by Company (2015-2020)
Table 41. United States Heparin Sales (K MT) by Type (2015-2020)
Table 42. United States Heparin Sales Market Share by Type (2015-2020)
Table 43. United States Heparin Sales (K MT) by Application (2015-2020)
Table 44. United States Heparin Sales Market Share by Application (2015-2020)
Table 45. Europe Heparin Sales (K MT) by Company (2015-2020)
Table 46. Europe Heparin Sales Market Share by Company (2015-2020)
Table 47. Europe Heparin Sales (K MT) by Type (2015-2020)
Table 48. Europe Heparin Sales Market Share by Type (2015-2020)
Table 49. Europe Heparin Sales (K MT) by Application (2015-2020)
Table 50. Europe Heparin Sales Market Share by Type (2015-2020)
Table 51. China Heparin Sales (K MT) by Company (2015-2020)
Table 52. China Heparin Sales Market Share by Company (2015-2020)
Table 53. China Heparin Sales (K MT) by Type (2015-2020)
Table 54. China Heparin Sales Market Share by Type (2015-2020)
Table 55. China Heparin Sales (K MT) by Application (2015-2020)
Table 56. China Heparin Sales Market Share by Application (2015-2020)
Table 57. Japan Heparin Sales (K MT) by Company (2015-2020)
Table 58. Japan Heparin Sales Market Share by Company (2015-2020)
Table 59. Japan Heparin Sales (K MT) by Type (2015-2020)
Table 60. Japan Heparin Sales Market Share by Type (2015-2020)
Table 61. Japan Heparin Sales (K MT) by Application (2015-2020)
Table 62. Japan Heparin Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Heparin Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Heparin Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Heparin Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Heparin Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Heparin Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Heparin Sales Market Share by Application (2015-2020)
Table 69. India Heparin Sales (K MT) by Company (2015-2020)
Table 70. India Heparin Sales Market Share by Company (2015-2020)
Table 71. India Heparin Sales (K MT) by Type (2015-2020)
Table 72. India Heparin Sales Market Share by Type (2015-2020)
Table 73. India Heparin Sales (K MT) by Application (2015-2020)
Table 74. India Heparin Sales Market Share by Application (2015-2020)
Table 75. Hepalink Corporation Information
Table 76. Hepalink Description and Business Overview
Table 77. Hepalink Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Hepalink Heparin Product
Table 79. Hepalink Recent Development
Table 80. Changshan Pharm Corporation Information
Table 81. Changshan Pharm Description and Business Overview
Table 82. Changshan Pharm Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Changshan Pharm Heparin Product
Table 84. Changshan Pharm Recent Development
Table 85. Qianhong Bio-pharma Corporation Information
Table 86. Qianhong Bio-pharma Description and Business Overview
Table 87. Qianhong Bio-pharma Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Qianhong Bio-pharma Heparin Product
Table 89. Qianhong Bio-pharma Recent Development
Table 90. Opocrin Corporation Information
Table 91. Opocrin Description and Business Overview
Table 92. Opocrin Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Opocrin Heparin Product
Table 94. Opocrin Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Pfizer Heparin Product
Table 99. Pfizer Recent Development
Table 100. Aspen Oss Corporation Information
Table 101. Aspen Oss Description and Business Overview
Table 102. Aspen Oss Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Aspen Oss Heparin Product
Table 104. Aspen Oss Recent Development
Table 105. King-friend Biochemical Pharmaceutical Corporation Information
Table 106. King-friend Biochemical Pharmaceutical Description and Business Overview
Table 107. King-friend Biochemical Pharmaceutical Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. King-friend Biochemical Pharmaceutical Heparin Product
Table 109. King-friend Biochemical Pharmaceutical Recent Development
Table 110. Bioibérica Corporation Information
Table 111. Bioibérica Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Bioibérica Description and Business Overview
Table 113. Bioibérica Heparin Product
Table 114. Bioibérica Recent Development
Table 115. Dongcheng Biochemicals Corporation Information
Table 116. Dongcheng Biochemicals Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Dongcheng Biochemicals Description and Business Overview
Table 118. Dongcheng Biochemicals Heparin Product
Table 119. Dongcheng Biochemicals Recent Development
Table 120. Jiulong Biochemicals Corporation Information
Table 121. Jiulong Biochemicals Description and Business Overview
Table 122. Jiulong Biochemicals Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Jiulong Biochemicals Heparin Product
Table 124. Jiulong Biochemicals Recent Development
Table 125. Tiandong Corporation Information
Table 126. Tiandong Description and Business Overview
Table 127. Tiandong Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Tiandong Heparin Product
Table 129. Tiandong Recent Development
Table 130. Xinbai Corporation Information
Table 131. Xinbai Description and Business Overview
Table 132. Xinbai Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Xinbai Heparin Product
Table 134. Xinbai Recent Development
Table 135. Yino Pharma Corporation Information
Table 136. Yino Pharma Description and Business Overview
Table 137. Yino Pharma Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Yino Pharma Heparin Product
Table 139. Yino Pharma Recent Development
Table 140. Deebio Corporation Information
Table 141. Deebio Description and Business Overview
Table 142. Deebio Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Deebio Heparin Product
Table 144. Deebio Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Heparin Distributors List
Table 148. Heparin Customers List
Table 149. Heparin Market Key Trends
Table 150. Heparin Key Opportunities and Drivers
Table 151. Heparin Market Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Heparin Product Picture
Figure 2. Global Heparin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Heparin Market Share by Application in 2020 & 2026
Figure 6. UFH Examples
Figure 7. LMWH Examples
Figure 8. Global Heparin Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Heparin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Heparin Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Heparin Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Heparin Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Heparin Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Heparin Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Heparin Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Heparin Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Heparin Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Heparin Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Heparin Players Market Share by Revenue in Heparin 2015 & 2019
Figure 26. Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Heparin Revenue Share by Type (2015-2020)
Figure 28. Global Heparin Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Heparin Revenue Share by Application (2015-2020)
Figure 30. Global Heparin Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Heparin Sales Market Share by Type in 2019
Figure 32. United States Heparin Sales Market Share by Type in 2019
Figure 33. Europe Heparin Sales Market Share by Company in 2019
Figure 34. Europe Heparin Sales Market Share by Type in 2019
Figure 35. Europe Heparin Sales Market Share by Application in 2019
Figure 36. China Heparin Sales Market Share by Company in 2019
Figure 37. China Heparin Sales Market Share by Type in 2019
Figure 38. China Heparin Sales Market Share by Application in 2019
Figure 39. Japan Heparin Sales Market Share by Company in 2019
Figure 40. Japan Heparin Sales Market Share by Type in 2019
Figure 41. Japan Heparin Sales Market Share by Application in 2019
Figure 42. Southeast Asia Heparin Sales Market Share by Company in 2019
Figure 43. Southeast Asia Heparin Sales Market Share by Type in 2019
Figure 44. Southeast Asia Heparin Sales Market Share by Application in 2019
Figure 45. India Heparin Sales Market Share by Company in 2019
Figure 46. India Heparin Sales Market Share by Type in 2019
Figure 47. India Heparin Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Heparin
Figure 50. Manufacturing Process Analysis of Heparin
Figure 51. Heparin Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
ヘパリンカルシウムの世界市場レポート2020 Market Analysis and Insights: Global Heparin Calcium Market The global Heparin Calcium market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Heparin Calcium Scope and Market Size The global Heparin Calcium market is segmented…- 低分子量ヘパリンの世界市場レポート2020 Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage. Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular wei…
- ヘパリンナトリウムの世界市場レポート2020 Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. In 2018, China heparin sodium production share took about…
- IVフラッシュシリンジの世界市場レポート2020 This report studies the IV Flush Syringe market. Health care professionals use IV flush syringes to clear out patients’ catheters and intravenous lines to ensure the tubes are sterile. Nurse Assist, a Texas-based medical device manufacturer, recalled all of its Normal Saline IV Flush Syringes in 201…
- 酪酸誘導体の世界市場レポート2020 Butyric acid derivatives are salts and esters of butyric acid also known as botanoic acid. Salts of butyric acid are predominant segment of butyric acid derivatives market. Salts of butyric acid include sodium butyrate, calcium butyrate, potassium butyrate, magnesium butyrate etc. Of these salts, so…